Similar articles

• Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.

  Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, Light JA, Gaber LW, Squiers E, Taylor RJ, Neylan JF, Steiner RW, Knechtle S, Norman DJ, Shihab F, Basadonna G, Brennan DC, Hodge EE, Kahan BD, Kahan L, Steinberg S, Woodle ES, Chan L, Ham JM, Schroeder TJ, et al. Gaber AO, et al. Transplantation. 1998 Jul 15;66(1):29-37. doi: 10.1097/00007890-199807150-00005. Transplantation. 1998. PMID: 9679818 Clinical Trial.
• A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.

  Brennan DC, Flavin K, Lowell JA, Howard TK, Shenoy S, Burgess S, Dolan S, Kano JM, Mahon M, Schnitzler MA, Woodward R, Irish W, Singer GG. Brennan DC, et al. Transplantation. 1999 Apr 15;67(7):1011-8. doi: 10.1097/00007890-199904150-00013. Transplantation. 1999. PMID: 10221486 Clinical Trial.
• Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.

  Gaber LW, Moore LW, Gaber AO, Tesi RJ, Meyer J, Schroeder TJ. Gaber LW, et al. Kidney Int. 1999 Jun;55(6):2415-22. doi: 10.1046/j.1523-1755.1999.00494.x. Kidney Int. 1999. PMID: 10354290 Clinical Trial.
• The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.

  Schroeder TJ, Moore LW, Gaber LW, Gaber AO, First MR. Schroeder TJ, et al. Transplant Proc. 1999 May;31(3B Suppl):1S-6S. doi: 10.1016/s0041-1345(99)00092-5. Transplant Proc. 1999. PMID: 10330958 Review.
• Thymoglobulin and its use in renal transplantation: a review.

  Thiyagarajan UM, Ponnuswamy A, Bagul A. Thiyagarajan UM, et al. Am J Nephrol. 2013;37(6):586-601. doi: 10.1159/000351643. Epub 2013 Jun 12. Am J Nephrol. 2013. PMID: 23774740 Review.